Amrutanjan Health Care Ltd

Amrutanjan Health Care Investor Presentation: Key Takeaways

Q2 FY27 net sales ₹135.2 Cr (+14.9%), PAT ₹17.3 Cr (+23.8%). H1 PAT ₹21.7 Cr, down 2.8% on cost pressure.

Amrutanjan Health Care Dividend

Amrutanjan Health Care set November 7, 2026 as the record date for its first FY2026-27 interim dividend. The dividend amount per share is not stated.

Amrutanjan Health Care Q2 FY27 Results: Net Profit ₹17.3 Cr, Up 23.6% YoY

Amrutanjan Health Care Ltd reported revenue from operations of ₹135.2 Cr (+14.9% YoY) and net profit of ₹17.3 Cr (+23.6% YoY) for Q2 FY27.

Key figure

Net profit ₹17.3 Cr · +23.6% YoY

Amrutanjan Health Care Board Meeting Date

Amrutanjan Health Care scheduled its board meeting for 3 Nov 2026 to consider Q2/H1 results and 1st interim dividend. No financial figures or dividend amount are stated in this advance intimation.

Amrutanjan Health Care Other Announcement

Amrutanjan Health Care received a voluntary CRISIL ESG rating of 'Adequate' (score 60). No capital or operational impact arises from this rating.

Amrutanjan Health Care Annual General Meeting

Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.

Amrutanjan Health Care Annual General Meeting

Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend of Rs. 2.90 per share.

Amrutanjan Health Care Annual General Meeting

Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend.

Value

₹0.06 Cr

Amrutanjan Health Care Business Update

Amrutanjan Health Care Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. This disclosure forms part of the company's Annual Report requirements.

Amrutanjan Health Care Annual Report

Amrutanjan Health Care Limited submitted its 89th Annual Report for the financial year 2025-26. The company scheduled its Annual General Meeting for September 23, 2026.

Amrutanjan Health Care Investor Presentation: Key Takeaways

Amrutanjan reported 9.48% revenue growth in Q1 FY27, driven by Women's Hygiene (21%) and Beverages (11.34%). Profitability was hit by a one-time INR 2.02 Cr lease rent provision.

Call

Guides 10% growth